STARTUP PROFILE

Samphire Neuroscience

COUNTRY
UK
FOUNDED
2021
CATEGORY
Neuromodulation
Pioneering a wearable brain-first neurotechnology, Nettle, that provides non-hormonal brain stimulation to reduce menstrual pain, low mood, and brain fog.
Visit website →
Neurofounders Insights
$   Funding   -
Seed
MODALITY
tDCS/tES
FORM FACTOR
Headset/cap
INTERFACE DEPTH
Non-invasive
INDICATION
Women's health
TARGET USER
Mixed
REGULATORY STAGE
CE-Marked
Samphire Neuroscience is differentiated by applying non-hormonal brain stimulation to women’s health symptoms such as menstrual pain, low mood, and brain fog. The indication choice is commercially interesting because it opens a relatively under-addressed segment of consumer-adjacent clinical neurotechnology.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Samphire Neuroscience